NHS Commended Guidelines

NHS Commended Guidelines

GASTROENTEROLOGY/DIGESTIVE SYSTEM

1. Helicobacter pylori and peptic ulcer (Effectiveness Matters - September 1995 Volume 1 Issue 2)

2. Laparoscopic surgery for the treatment of colorectal cancer (NICE) Technology Appraisal 105 - August 2006

3. Laparoscopic surgery for inguinal hernia repair (NICE) Technology Appraisal 83 - September 2004

4. Management of upper gastro-intestinal cancers (Effective Health Care - October 2000 Volume 6 Number 4)

5. Dyspepsia: Managing dyspepsia in adults in primary care (NICE) Clinical guidelines CG17 - August 2004

6. Effectiveness of laxatives in adults (Effective Health Care - September 2001 Volume 7 Issue 1)

7. Guidance on the use of infliximab for Crohn’s disease (NICE) Technology Appraisal Guidance - No.40 - April 2002

8. Antimicrobial prophylaxis in colorectal surgery (Effective Health Care - October 1998 Volume 4 Number 5)

9. Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (NICE) Technology appraisal 86 - October 2004

10. Stapled haemorrhoidopexy for the treatment of haemorrhoids (NICE) Technology Appraisal Guidance 128 - September 2007

11. Infliximab for subacute manifestations of ulcerative colitis (NICE) Technology Appraisal Guidance 140 - April 2008

12. Infliximab for acute exacerbations of ulcerative colitis (NICE) Technology Appraisal Guidance 163 - December 2008

CARDIOVASCULAR

1. Investigation and management of stable angina: revised guidelines 1998 (Joint Working Party of the British Cardiac Society and Royal College of Physicians of London)

2. Cardiac rehabilitation (Effective Health Care - October 1998 Volume 4 Number 4)

3. Cholesterol and coronary heart disease: Screening and treatment(Effective Health Care - February 1998 Volume 4 Number 1)

4. Management of stable angina (Effective Health Care - October 1997 Volume 3 Number 5)

5. Aspirin and myocardial infarction (Effectiveness Matters - 1995 Volume 1 Issue 1)

6. The primary care management of stable angina (COmputerised Guidelines Evaluation in the NorTh of England (COGENT) - 2007) Family Practice - 18 (2) pp 217 - 222 (2001)

7. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction (NICE) Technology Appraisal Guidance - No.73 - November 2003

8. Drug treatment of essential hypertension in older people (Effectiveness Matters - October 1999 Volume 4 Number 2)

9. Guidance on on the use of coronary artery stents (NICE) Technology Appraisal 71 - October 2003

10. Drug-eluting stents for the treatment of coronary artery disease (part review of NICE technology appraisal guidance 71) (NICE) Technology Appraisal 152 - July 2008

11. Implantable cardioverter defibrillators for arrhythmias: Review of Technology Appraisal 11 (NICE) Technology Appraisal 95 - January 2006

12. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (NICE) Technology Appraisal Guidance - No.47 - September 2002

13. Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome (NICE) Technology Appraisal 80 - July 2004

14. Endovascular stent–grafts for the treatment of abdominal aortic aneurysms (NICE) Technology Appraisal Guidance 167 - February 2009

15. Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block (NICE) Technology Appraisal 88 - February 2005

16. Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (NICE) Clinical guidelines CG67 - May 2008

17. Cardiac resynchronisation therapy for the treatment of heart failure (NICE) Technology Appraisal Guidance 120 - May 2007

18. Alteplase for the treatment of acute ischaemic stroke (NICE) Technology Appraisal Guidance 122 - June 2007

19. Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (NICE) Technology Appraisal Guidance - No.52 - October 2002

20. Clopidogrel and modified release dipyridamole in the prevention of occlusive vascular events (NICE) Technology Appraisal 90 - May 2005

21. Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults (NICE) Technology Appraisal Guidance 157 - September 2008

22. Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (NICE) Technology Appraisal Guidance 170 - April 2009

CHD and Stroke Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

Other Vascular Disease Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

INFECTION/COMMUNICABLE DISEASES

1. Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C (NICE) Technology Appraisal Guidance 106 - August 2006

2. Saving Lives: reducing infection, delivering clean and safe care (Department of Health - 21 June 2007)

3. Drug Misuse and Dependence: Guidelines on Clinical Management (Department of Health - 15 March 1999)

4. Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B (NICE) Technology Appraisal 96 - February 2006

5. Entecavir for the treatment of chronic hepatitis B (NICE) Technology Appraisal Guidance 153 - August 2008

6. Telbivudine for the treatment of chronic hepatitis B (NICE) Technology Appraisal Guidance 154 - August 2008

7. TInterferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C (NICE) Technology Appraisal 75 - January 2004

8. Drotrecogin alfa (activated) for severe sepsis (NICE) Technology appraisal 84 - September 2004

9. Tenofovir disoproxil for the treatment of chronic hepatitis B (NICE) Technology Appraisal Guidance 173 - July 2009

RESPIRATORY

1. Guidance on inhaler systems (devices) for children under the age of 5 years with chronic asthma (NICE) Technology Appraisal Guidance - No.10 - August 2000

2. Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years) (NICE) Technology Appraisal Guidance - No.38 - March 2002

3. Inhaler devices for the management of asthma and COPD (Effective Health Care - 2003 Volume 8 Number 1)

4. Omalizumab for severe persistent allergic asthma (NICE) Technology Appraisal Guidance 133 - November 2007

5. Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over (NICE) Technology Appraisal Guidance 138 - March 2008

6. Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years (NICE) Technology Appraisal Guidance 131 - November 2007

Respiratory Medicine Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

British guideline on the management of asthma Guideline No. 101 (May 2008) (Scottish Intercollegiate Guidelines Network (SIGN))

CENTRAL NERVOUS SYSTEM

1. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease (amended) (NICE) Technology Appraisal Guidance 111 (amended) - November 2006 (amended September 2007)

2. Guidance on the use of Riluzole (Rilutek) for the treatment of motor neurone disease (NICE) Technology Appraisal Guidance - No.20 - January 2001

3. Beta interferon and glatiramer acetate for the treatment of multiple sclerosis (NICE) Technology Appraisal Guidance - No.32 - January 2002

4. Interventions for the management of CFS/ME (Effective Health Care - 2002 Volume 7 Number 4)

5. Newer drugs for epilepsy in adults (NICE) Technology appraisal 76 - March 2004

6. Newer drugs for epilepsy in children (NICE) Technology appraisal 79 - April 2004

7. Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis (NICE) Technology Appraisal Guidance 127 - August 2007

8. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin (NICE) Technology Appraisal Guidance 159 - October 2008

Diagnosis and management of headache in adults Guideline No. 107 (November 2008) (Scottish Intercollegiate Guidelines Network (SIGN))

Early management of patients with a head injury Guideline No. 110 (May 2009) (Scottish Intercollegiate Guidelines Network (SIGN))

MENTAL HEALTH

1. Drug treatments for Schizophrenia (Effective Health Care - December 1999 Volume 5 Number 6)

2. Mental health promotion in high risk groups (Effective Health Care - June 1997 Volume 3 Number 3)

3. Drug misuse and dependence - guidelines on clinical management (Department of Health - 15 March 1999)

4. Psychosocial interventions for schizophrenia (Effective Health Care - August 2000 Volume 6 Number 3)

5. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (NICE) Technology Appraisal 98 - March 2006

6. Core interventions in the treatment and management of schizophrenia in primary and secondary care (update) (NICE) Clinical guidelines CG82 - March 2009

7. Treatment choice in psychological therapies and counselling (Department of Health - 19 February 2001)

8. Improving the recognition and management of depression in primary care (Effective Health Care - 2002 Volume 7 Number 5)

9. Computerised cognitive behaviour therapy for depression and anxiety - Review of Technology Appraisal 51 (NICE) Technology appraisal 97 - February 2006

10. Guidance on the use of electroconvulsive therapy (NICE) Technology Appraisal 59 - April 2003

11. Brief interventions and alcohol use (Effective Health Care - November 1993 Number 7)

12. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care (NICE) Clinical guidelines CG38 - July 2006

13. Parent-training/education programmes in the management of children with conduct disorders (NICE) Technology appraisal guidance 102 - July 2006

14. Methadone and buprenorphine for the management of opioid dependence (NICE) Technology appraisal guidance 114 - January 2007

15. Naltrexone for the management of opioid dependence (NICE) Technology appraisal guidance 115 - January 2007

16. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (NICE) Technology appraisal 77 - April 2004

17. Structural neuroimaging in first-episode psychosis (NICE) Technology Appraisal Guidance 136 - February 2008

Mental Health Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

ENDOCRINE

1. Recommendations for the management of diabetes in primary care (Diabetes UK - 2005)

2. Complications of diabetes: Screening for retinopathy and management of foot ulcers (Effective Health Care - August 1999 Volume 5 Number 4)

3. Complications of diabetes: renal disease and promotion of self-management (Effective Health Care - March 2000 Volume 6 Number 1)

4. Type 2 Diabetes: National clinical guideline for management in primary and secondary care (update) (NICE) Clinical guidelines CG66 - May 2008

5. Type 2 diabetes: Newer agents for blood glucose control in type 2 diabetes (NICE) Clinical guidelines CG87 - May 2009

6. Guidance on the use of long-acting insulin analogues for the treatment of diabetes - insulin glargine (NICE) Technology Appraisal Guidance - No.53 - December 2002

7. Guidance on the use of continuous subcutaneous insulin infusion for diabetes (NICE) Technology Appraisal Guidance - No.151 - July 2008

8. Guidance on the use of patient-education models for diabetes (NICE) Technology Appraisal Guidance - No.60 - April 2003

9. Human growth hormone (somatropin) in adults with growth hormone deficiency (NICE) Technology Appraisal Guidance - No.64 - August 2003

10. Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (NICE) Technology Appraisal Guidance 117 - January 2007

Diabetes Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

OBSTETRICS. GYNAECOLOGY & UROLOGY

1. Benign prostatic hyperplasia (Effective Health Care - December 1995 Volume 2 Number 2)

2. Preventing and reducing the adverse effects of unintended teenage pregnancies (Effective Health Care - February 1997 Volume 3 Number 1)

3. The management of menorrhagia (Effective Health Care - 1995 Volume 1 Number 9)

4. The management of gynaecological cancers (Effective Health Care - June 1999 Volume 5 Number 3)

5. Guidance on the use of paclitaxel in the treatment of ovarian cancer (NICE) Technology Appraisal Guidance - No.55 - January 2003

6. Guidance on the use of liquid based cytology for cervical screening (NICE Technology Appraisal Guidance 69 - October 2003

7. Promoting the initiation of breastfeeding (Effective Health Care - July 2000 Volume 6 Number 2)

8. Full clinical guideline on the use of electronic fetal monitoring (Published by the Royal College of Obstetricians and Gynaecologists) (Evidence Based Clinical Guideline - No.8 - May 2001)

9. Induction of labour (NICE) Clinical guidelines CG70 - July 2008

10. Advanced breast cancer: Diagnosis and treatment (NICE) Clinical guidelines CG81- February 2009

11. Guidance on the use of trastuzumab for the treatment of advanced breast cancer (NICE) Technology Appraisal Guidance - No.34 - March 2002

12. Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer (NICE) Technology Appraisal Guidance 112 - November 2006

13. Routine antenatal anti-D prophylaxis for women who are rhesus D negative (NICE) Technology Appraisal Guidance 156 - August 2008

14. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer (NICE) Technology Appraisal Guidance 91 - May 2005

15. Urinary incontinence: The management of urinary incontinence in women (NICE) Clinical guidelines CG40 - October 2006

16. Treating nocturnal enuresis in children (Effective Health Care - 2003 Volume 8 Number 2)

17. Diagnosing urinary tract infection (UTI) in the under fives (Effective Health Care - 2004 Volume 8 Number 6)

18. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (NICE) Technology Appraisal Guidance - No.48 - September 2002

19. Gemcitabine for the treatment of metastatic breast cancer (NICE) Technology Appraisal Guidance 116 - January 2007

20. Febuxostat for the management of hyperuricaemia in people with gout (NICE) Technology Appraisal Guidance 164 - December 2008

21. Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding (NICE) Technology Appraisal 78 - April 2004

22. Machine perfusion systems and cold static storage of kidneys from deceased donors (NICE) Technology Appraisal Guidance 165 - January 2009

23. Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (NICE) Technology Appraisal Guidance 169 - March 2009

24. Immunosuppressive therapy for renal transplantation in adults (NICE) Technology Appraisal 85 - September 2004

25. Immunosuppressive therapy for renal transplantation in children and adolescents (NICE) Technology Appraisal 99 - April 2006

Obstetrics and Gynaecology Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

MALIGNANT DISEASE

1. Guidelines for the referral of patients with breast problems (NHS Breast Screening Programme and The Cancer Research Campaign)

2. Management of lung cancer (Effective Health Care - June 1998 Volume 4 Number 3)

3. The management of colorectal cancer (Effective Health Care - December 1997 Volume 3 Number 6)

4. The management of primary breast cancer (Effective Health Care - August 1996 Volume 2 Number 6)

5. Screening for prostate cancer (Effectiveness Matters - February 1997 Volume 2 Issue 2)

6. Guidelines for managing cancer pain in adults (National Council for Hospice and Specialist Palliative Care Services [3rd Ed] June 2003))

7. The management of gynaecological cancers (Effective Health Care - June 1999 Volume 5 Number 3)

8. Management of upper gastro-intestinal cancers (Effective Health Care - October 2000 Volume 6 Number 4)

9. Advanced breast cancer: Diagnosis and treatment (NICE) Clinical guidelines CG81- February 2009

10. Early and locally advanced breast cancer: Diagnosis and treatment (NICE) Clinical guidelines CG80 - February 2009

11. Guidance on the use of paclitaxel in the treatment of ovarian cancer (NICE) Technology Appraisal Guidance - No.55 - January 2003

12. Laparoscopic surgery for colorectal cancer (NICE) Technology Appraisal Guidance 105 - August 2006

13. Informing, communicating and sharing decisions with people who have cancer (Effective Health Care - December 2000 Volume 6 Number 6)

14. Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma (NICE) Technology Appraisal Guidance 121 - June 2007

15. Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) (NICE) Technology Appraisal Guidance - No.23 - April 2001

16. Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal) (NICE) Technology Appraisal Guidance 149 - June 2008

17. Guidance on the use of gemcitabine for pancreatic cancer (NICE) Technology Appraisal Guidance - No.25 - May 2001

18. The diagnosis and treatment of lung cancer: Methods, evidence and guidance (NICE) Clinical guidelines CG24 - November 2008

19. Erlotinib for the treatment of non-small cell lung cancer (NICE) Technology Appraisal Guidance 162 - November 2008

20. Pemetrexed for the treatment of non-small-cell lung cancer (NICE) Technology Appraisal Guidance 124 - August 2007

21. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer (NICE) Technology Appraisal Guidance 91 - May 2005

22. Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia (NICE) Technology Appraisal Guidance 119 - February 2007

23. Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer (NICE) Technology Appraisal 93 - August 2005

24. Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer (NICE) Technology Appraisal 91 - May 2005

25. Guidance on the use of imatinib for chronic myeloid leukaemia (NICE) Technology Appraisal 70 - October 2003

26. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer (NICE) Technology Appraisal Guidance - No.61 - May 2003

27. Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 145 - June 2008

28. Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 172 - June 2009

29. Capecitabine and oxaliplatinin the adjuvant treatment of stage III (Dukes’ C) colon cancer (NICE) Technology Appraisal 100 - April 2006

30. Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer (NICE) Technology Appraisal 118 - January 2007

31. Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (NICE) Technology appraisal 86 - October 2004

32. Pemetrexed for the treatment of malignant pleural mesothelioma (NICE) Technology Appraisal Guidance 135 - January 2008

33. Docetaxel for the treatment of hormone-refractory metastatic prostate cancer (NICE) Technology Appraisal Guidance 101 - June 2006

34. Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (NICE) Technology Appraisal Guidance 169 - March 2009

35. Rituximab for the first-line treatment of chronic lymphocytic leukaemia (NICE) Technology Appraisal Guidance 174 - July 2009

36. Gefitinib for the second-line treatment of locally advanced or metastatic non-small-cell lung cancer (terminated appraisal) (NICE) Technology Appraisal 175 - August 2009

37. Cetuximab for the first-line treatment of metastatic colorectal cancer (NICE) Technology Appraisal Guidance 176 - August 2009

38. Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (NICE) Technology Appraisal Guidance 178 - August 2009

Cancer Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

HAEMATOLOGY/LYMPHATIC SYSTEM

1. Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia (NICE) Technology Appraisal Guidance 142 - May 2008

2. Rituximab for the treatment of follicular lymphoma (NICE) Technology Appraisal Guidance 110 - September 2006

3. Bortezomib monotherapy for relapsed multiple myeloma (NICE) Technology Appraisal Guidance 129 - October 2007

4. Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy (NICE) Technology Appraisal Guidance 171 - June 2009

5. Rituximab for aggressive non-Hodgkin’s lymphoma (NICE) Technology Appraisal 65 - September 2003

NUTRITION

1. The prevention and treatment of obesity(Effective Health Care - April 1997 Volume 3 Number 2)

2. Obesity guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children (NICE) Clinical guidelines CG43 - December 2006

3. Guidance on the use of human growth hormone (somatropin) in children with growth failure (NICE) Technology Appraisal Guidance - No.42 - May 2002

4. The prevention and treatment of childhood obesity (Effective Health Care - 2002 Volume 7 Number 6)

5. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia (NICE) Technology Appraisal Guidance 132 - November 2007

SURGERY

1. Surgical site infection: Prevention and treatment of surgical site infection (NICE) Clinical guidelines CG74 - October 2008

2. Pre-hospital initiation of fluid replacement therapy in trauma (NICE) Technology appraisal 74 - January 2004

Surgery Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

MUSCULOSKELETAL & JOINTS

1. Primary care guide on the prevention and treatment of osteoporosis (Department of Health & Royal College of Physicians - June 1998)

2. Upper limb disorders: Occupational aspects of management (Royal College of Physicians - June 2009)

3. Rheumatoid arthritis: National clinical guideline for management and treatment in adults (Royal College of Physicians - February 2009)

4. Osteoarthritis: National clinical guideline for care and management in adults (Royal College of Physicians - February 2008)

5. Glucocorticoid-induced osteoporosis: Guidelines for prevention and treatment (Royal College of Physicians - December 2002)

6. Total hip replacement (Effective Health Care - October 1996 Volume 2 Number 7)

7. Clinical guidelines for the management of acute low back pain (Royal College of General Practitioners)

8. Guidance on the selection of prostheses for primary total hip replacement (NICE) Technology Appraisal Guidance - No.2 - April 2000

9. Guidance on the use of metal on metal hip resurfacing arthroplasty (NICE) Technology Appraisal Guidance - No.44 - June 2002

10. The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints (NICE) Technology Appraisal 89 - May 2005

11. Acute and chronic low back pain (Effective Health Care - November 2000 Volume 6 Number 5)

12. Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis (NICE) Technology Appraisal Guidance - No.35 - March 2002

13. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis (Partially replaced by TA130) (NICE) Technology Appraisal Guidance - No.36 - March 2002

14. Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis (NICE) Technology Appraisal Guidance 130 - October 2007

15. Abatacept for the treatment of rheumatoid arthritis (NICE) Technology Appraisal Guidance 141 - April 2008

16. Rituximab for the treatment of rheumatoid arthritis (NICE) Technology Appraisal Guidance 126 - August 2007

17. Adalimumab, etanercept and infliximab for ankylosing spondylitis (NICE) Technology Appraisal Guidance 143 - May 2008

18. Osteoarthritis: National clinical guideline for care and management in adults (NICE) Clinical guidelines CG59 - February 2008

19. Rheumatoid arthritis: National clinical guideline for care and management in adults (NICE) Clinical guidelines CG79 - February 2009

20. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (NICE) Technology Appraisal Guidance 160 - October 2008

21. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (NICE) Technology Appraisal Guidance 161 - October 2008

22. Adalimumab for the treatment of psoriatic arthritis (NICE) Technology Appraisal Guidance 125 - August 2007

23. Etanercept and infliximab for the treatment of adults with psoriatic arthritis (NICE) Technology Appraisal Guidance 104 - July 2006

Orthopaedics Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

EYE, EAR NOSE AND THROAT

1. Management of cataract (Effective Health Care - February 1996 Volume 2 Number 3)

2. The treatment of persistent glue ear in children (Effective Health Care - November 1992 Number 4)

3. Cochlear implants for children and adults with severe to profound deafness (NICE) Technology Appraisal Guidance 166 - January 2009

4. Complications of diabetes: Screening for retinopathy and management of foot ulcers (Effective Health Care - August 1999 Volume 5 Number 4)

5. Pre-school hearing, speech, language and vision screening (Effective Health Care - April 1998 Volume 4 Number 2)

6. Royal College of Speech & Language Therapists Clinical Guidelines (Royal College of Speech and Language Therapists - 2005)

7. Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 145 - June 2008

8. Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck (NICE) Technology Appraisal Guidance 172 - June 2009

9. Guidance on the use of photodynamic therapy for age-related macular degeneration (NICE) Technology Appraisal 68 - September 2003

10. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration (NICE) Technology Appraisal Guidance 155 - August 2008

11. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (NICE) Technology Appraisal Guidance 139 - March 2008

ENT Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

DENTISTRY, ORAL SURGERY

1. Guidance on the extraction of wisdom teeth (NICE) Technology Appraisal Guidance - No.1 - March 2000

2. Dental restoration: what type of filling? (Effective Health Care - April 1999 Volume 5 Number 2)

3. HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries) (NICE) Technology Appraisal 92 - July 2005

Dentistry Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

SKIN

1. Compression therapy for venous leg ulcers (Effective Health Care - August 1997 Volume 3 Number 4)

2. The prevention and treatment of pressure sores (Effective Health Care - October 1995 Volume 2 Number 1)

3. Treating head lice and scabies (Effectiveness Matters - June 1999 Volume 4 Issue 1)

4. The management of pressure ulcers in primary and secondary care: A clinical practice guideline (NICE) Clinical guidelines CG29 - September 2005

5. Frequency of application of topical corticosteroids for atopic eczema (NICE) Technology Appraisal 81 - August 2004

6. Tacrolimus and pimecrolimus for atopic eczema (NICE) Technology Appraisal 82 - August 2004

7. Adalimumab for the treatment of adults with psoriasis (NICE) Technology Appraisal Guidance 146 - June 2008

8. Etanercept and efalizumab for the treatment of adults with psoriasis (NICE) Technology Appraisal Guidance 103 - July 2006

9. Infliximab for the treatment of adults with psoriasis (NICE) Technology Appraisal Guidance 134 - January 2008

10. Alitretinoin for the treatment of severe chronic hand eczema (NICE) Technology Appraisal Guidance 177 - August 2009

IMMUNISATION AND VACCINATION

1. Summary of flu immunisation policy (Department of Health - 30 April 2009)

2. Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza (NICE) Technology Appraisal Guidance 158 - September 2008

3. Amantadine, oseltamivir and zanamivir for the treatment of influenza (NICE) Technology Appraisal Guidance 168 - February 2009

GENERAL

1. Implementing clinical practice guidelines (Effective Health Care - December 1994 Number 8)

2. Hospital volume and health care outcomes, costs and patient access (Effective Health Care - December 1996 Volume 2 Number 8)

3. Preventing unintentional injuries in children and young adolescents (Effective Health Care - June 1996 Volume 2 Number 5)

4. Smoking cessation: What the health service can do (Effectiveness Matters - March 1998 Volume 3 Number 1)

5. Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities (NICE) Public Health Guidance 10 - February 2008

6. Varenicline for smoking cessation (NICE) Technology Appraisal Guidance 123 - July 2007

7. Making the best use of a department of clinical radiology (The Royal College of Radiologists: (6th edition) 2007)

8. Deliberate self-harm (Effective Health Care - December 1998 Volume 4 Number 6)

9. Getting evidence into practice (Effective Health Care - February 1999 Volume 5 Number 1)

10. Preventing falls and subsequent injury in older people (Effective Health Care - April 1996 Volume 2 Number 4)

11. Preventing the uptake of smoking in young people (Effective Health Care - October 1999 Volume 5 Number 5)

12. Acupuncture (Effective Health Care - November 2001 Volume 7 Number 2)

13. Homeopathy (Effective Health Care - 2002 Volume 7 Number 3)

14. Guidance on the use of ultrasound locating devices for placing central venous catheters (NICE) Technology Appraisal Guidance - No.49 - September 2002

Child Health Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

Sexually Transmitted Diseases Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))

Other Guidelines (Scottish Intercollegiate Guidelines Network (SIGN))